(Q44767670)

6 December 2017

title

Chronic hepatitis B management based on standard guidelines in community primary care and specialty clinics (English)

1 reference

6 December 2017

1 reference

Kevin C Ku

1

1 reference

6 December 2017

Jiayi Li

2

1 reference

6 December 2017

Nghi B Ha

3

1 reference

6 December 2017

Marina Martin

4

1 reference

6 December 2017

Vincent G Nguyen

5

1 reference

6 December 2017

Mindie H Nguyen

6

1 reference

6 December 2017

publication date

1 December 2013

1 reference

Digestive Diseases and Sciences

6 December 2017

published in

1 reference

6 December 2017

volume

58

1 reference

6 December 2017

issue

12

1 reference

6 December 2017

page(s)

3626-3633

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-013-2889-1

6 December 2017

exact match

0 references

cites work

Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Is there a downgrading in the alert about the hepatitis B virus infection in Italy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Molecular viral oncology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Hepatitis B awareness, knowledge, and screening among Asian Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

A simulation shows that early treatment of chronic hepatitis B infection can cut deaths and be cost-effective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Chronic hepatitis B: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Natural history of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Serum aminotransferase activity and mortality risk in a United States community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

The clinical significance of persistently normal ALT in chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Evaluation of current treatment recommendations for chronic hepatitis B: a 2011 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

The management of chronic hepatitis B in Asian Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: A region-wide survey in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Evidence for the insufficient evaluation and undertreatment of chronic hepatitis B infection in a predominantly low-income and immigrant population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Primary care physicians' approach to diagnosis and treatment of hepatitis B and hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Medical care of hepatitis B among Asian American populations: perspectives from three provider groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Hepatitis B knowledge, testing, and vaccination among Chinese and Vietnamese adults in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Hepatitis B awareness, testing, and knowledge among Vietnamese American men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Understanding cultural barriers in hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

San Francisco hep B free: a grassroots community coalition to prevent hepatitis B and liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Referral of chronic hepatitis B patients from primary to specialist care: making a simple guideline work

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Accuracy of a referral guideline for patients with chronic hepatitis B in primary care to select patients eligible for evaluation by a specialist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2889-1

Family physicians' knowledge and screening of chronic hepatitis and liver cancer.

21 January 2018

1 reference

12 December 2020

Characteristics of persons with chronic hepatitis B--San Francisco, California, 2006.

1 reference

12 December 2020

Chronic hepatitis B: perceptions in Asian American communities and diagnosis and management practices among primary care physicians

1 reference

12 December 2020

Hepatitis B knowledge and practices among Cambodian Americans

1 reference

12 December 2020

Attitudes toward hepatitis B and liver cancer prevention among Chinese Americans in the San Francisco Bay Area, California.

1 reference

12 December 2020

1 reference

12 December 2020

Risk perceptions and barriers to Hepatitis B screening and vaccination among Vietnamese immigrants

1 reference

12 December 2020

Chronic hepatitis B - a clinical audit of GP management

1 reference

12 December 2020

Screening for chronic hepatitis B among Asian/Pacific Islander populations--New York City, 2005

1 reference

12 December 2020

Rising incidence of hepatocellular carcinoma in the United States

1 reference

12 December 2020

10.1007/S10620-013-2889-1

Identifiers

DOI

1 reference

release_l4wc54t6j5hojgfxmvw57vmlim

6 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l4wc54t6j5hojgfxmvw57vmlim

24 November 2022

mapped directly with Wikidata item

1 reference